These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29232269)

  • 1. MR-guided biopsy and focal therapy: new options for prostate cancer management.
    Elkhoury FF; Simopoulos DN; Marks LS
    Curr Opin Urol; 2018 Mar; 28(2):93-101. PubMed ID: 29232269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.
    Nassiri N; Chang E; Lieu P; Priester AM; Margolis DJA; Huang J; Reiter RE; Dorey FJ; Marks LS; Natarajan S
    J Urol; 2018 Feb; 199(2):453-458. PubMed ID: 28830754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning.
    Sidelsky S; Setia S; Vourganti S
    Curr Urol Rep; 2017 Oct; 18(12):93. PubMed ID: 29046984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.
    Natarajan S; Jones TA; Priester AM; Geoghegan R; Lieu P; Delfin M; Felker E; Margolis DJA; Sisk A; Pantuck A; Grundfest W; Marks LS
    J Urol; 2017 Oct; 198(4):839-847. PubMed ID: 28396184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
    Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
    Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
    von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
    Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer.
    Choi YH; Yu JW; Kang MY; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    World J Urol; 2019 Oct; 37(10):2129-2135. PubMed ID: 30603783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR-Guided Prostate Interventions.
    Woodrum DA; Gorny KR; Mynderse LA
    Top Magn Reson Imaging; 2018 Jun; 27(3):141-151. PubMed ID: 29870466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.
    Costa DN; Goldberg K; Leon AD; Lotan Y; Xi Y; Aziz M; Freifeld Y; Margulis V; Raj G; Roehrborn CG; Hornberger B; Desai N; Bagrodia A; Francis F; Pedrosa I; Cadeddu JA
    Eur Urol Oncol; 2019 Jul; 2(4):397-404. PubMed ID: 31277776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-Bore MRI-guided Prostate Biopsies: Retrospective Observational Study of Complementary Nontargeted Sampling of Normal-appearing Areas at Multiparametric MRI.
    Elfatairy KK; Filson CP; Sanda MG; Osunkoya AO; Nour SG
    Radiol Imaging Cancer; 2019 Nov; 1(2):e190016. PubMed ID: 33778681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-ultrasound fusion for guidance of targeted prostate biopsy.
    Marks L; Young S; Natarajan S
    Curr Opin Urol; 2013 Jan; 23(1):43-50. PubMed ID: 23138468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective, Lesion Based Analyses of Patients Treated with Radical Prostatectomy.
    Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Tian Z; Karakiewicz PI; Tilki D; Fisch M; Maurer T; Graefen M; Budäus L
    J Urol; 2020 Feb; 203(2):299-303. PubMed ID: 31483694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New advances in focal therapy for early stage prostate cancer.
    Tay KJ; Schulman AA; Sze C; Tsivian E; Polascik TJ
    Expert Rev Anticancer Ther; 2017 Aug; 17(8):737-743. PubMed ID: 28635336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
    Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S
    Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
    Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
    Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy.
    Kaufmann S; Mischinger J; Amend B; Rausch S; Adam M; Scharpf M; Fend F; Kramer U; Notohamiprodjo M; Nikolaou K; Stenzl A; Bedke J; Kruck S
    World J Urol; 2017 Jul; 35(7):1023-1029. PubMed ID: 27847972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3.0-T MR-guided transgluteal in-bore-targeted prostate biopsy under local anesthesia in patients without rectal access: a single-institute experience and review of literature.
    Bera K; Ramaiya N; Paspulati RM; Nakamoto D; Tirumani SH
    Abdom Radiol (NY); 2024 Apr; 49(4):1223-1230. PubMed ID: 38383816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.